They are not doing the same thing
To observe the direct effect of semaglutide on the heart and blood vessels independent of its well-known weight loss effect, the animals were separated into two groups: one group received weekly injections of a low dose of semaglutide and the second group, the control group, received a placebo injection
Gastrointestinal effects Every GLP-1 based medication shares a core set of gastrointestinal side effects because they stem from the mechanism of action itself, slowing gastric emptying and altering gut motility
Emotional eating, stress and unhealthy relationships with food can sabotage weight loss efforts
Potential Interactions Between These Two Medicines No formal interaction studies exist, but pharmacodynamic interactions are a key concern tesamorelin raises blood glucose whilst retatrutide lowers it, making the combined glycaemic effect unpredictable and requiring close clinical monitoring